NIBMSZS: Neuroimaging Biomarker for Seizures

Sponsor
Providence VA Medical Center (U.S. Fed)
Overall Status
Active, not recruiting
CT.gov ID
NCT03441867
Collaborator
University of Alabama at Birmingham (Other), Rhode Island Hospital (Other), Birmingham, Alabama VA Medical Center (U.S. Fed), United States Department of Defense (U.S. Fed), Ocean State Research Institute, Inc. (Other), Brown University (Other)
224
3
4
60
74.7
1.2

Study Details

Study Description

Brief Summary

This multi-site study will examine patients with epilepsy (ES) following head injury [i.e., posttraumatic epilepsy (PTE)] and posttraumatic psychogenic Non-epileptic seizures (PNES) and will compare them to patients with traumatic brain injury (TBI) who do not have seizures using functional neuroimaging.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Behavioral Therapy for Seizures
  • Other: Standard Medical Care
N/A

Detailed Description

Numerous Veterans and civilians have seizures, which can be epileptic or nonepileptic in nature. Epileptic seizures are caused by abnormal brain cell firing. Nonepileptic seizures appear similar to epileptic seizures, but are associated with traumatic experiences and underlying psychological stressors. Both types of seizure are common and disabling, and many patients with seizures do not have adequate control resulting in loss of quality of life.

In this proposed 3-site study ( Providence, RI and Birmingham, AL), which are epilepsy centers with expertise both in epilepsy and psychogenic nonepileptic seizures (PNES), we will enroll 88 patients with video-EEG confirmed PNES and 88 with confirmed post-traumatic epilepsy (PTE) and will obtain functional neuroimaging before and after they receive a behavioral treatment - Cognitive Behavioral Therapy for Seizures. The functional neuroimaging studies in these patients will be compared to patients with traumatic brain injury without seizures to test the hypothesis that the faulty processing of emotions and stress in patients with PNES/PTE and abnormal brain connectivity have unique signals in patients with seizures compared to Veterans without seizures and that the neuroimaging signatures can be modified using behavioral intervention.

Impact: This grant application for the first study investigating mechanisms of PNES and PTE will provide increased understanding of neural circuitry in PTE and PNES, which can inform PTE and PNES treatments and could change clinical neurologic and psychiatric practice for PTE and PNES.

Participants will be recruited at the Providence VA Medical Center, Rhode Island Hospital, and University of Alabama, Birmingham (UAB).

Study Design

Study Type:
Interventional
Actual Enrollment :
224 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Masking Description:
The neuroimaging analysis will be masked.
Primary Purpose:
Treatment
Official Title:
Neuroimaging Biomarker for Seizures
Actual Study Start Date :
Sep 15, 2017
Anticipated Primary Completion Date :
May 15, 2022
Anticipated Study Completion Date :
Sep 14, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: (CBT-Sz) - PNES

Participants with history of a head injury and confirmed Psychogenic Non-Epileptic Seizures will complete 2 brain fMRI scans along with 12 weeks of one hour CBT-Sz sessions by a trained therapist.

Behavioral: Cognitive Behavioral Therapy for Seizures
CBT-informed psychotherapy for patients with PNES and PTE
Other Names:
  • Cognitive Behavioral Therapy (CBT-Sz)
  • (CBT-Sz) - PNES
  • (CBT-Sz) - PTE
  • Experimental: (CBT-Sz) - PTE

    Participants with history of a head injury and confirmed Post-Traumatic Epilepsy (PTE) will complete 2 brain fMRI scans along with 12 weeks of one hour CBT-Sz sessions by a trained therapist.

    Behavioral: Cognitive Behavioral Therapy for Seizures
    CBT-informed psychotherapy for patients with PNES and PTE
    Other Names:
  • Cognitive Behavioral Therapy (CBT-Sz)
  • (CBT-Sz) - PNES
  • (CBT-Sz) - PTE
  • Active Comparator: TBI Control

    Participants with TBI will complete 2 brain fMRI scans.

    Other: Standard Medical Care
    Observational - standard medical care
    Other Names:
  • Treatment as Usual
  • Active Comparator: Healthy Volunteer

    Healthy control volunteers will complete 2 brain fMRI scans.

    Other: Standard Medical Care
    Observational - standard medical care
    Other Names:
  • Treatment as Usual
  • Outcome Measures

    Primary Outcome Measures

    1. Number of Epileptic Seizures [Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baseline]

      epileptic seizure frequency (ES), collected prospectively, using a daily seizure calendar

    2. Number of Nonepileptic Seizures (NES) [Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baseline]

      psychogenic nonepileptic seizure (NES) frequency, collected prospectively, using a daily seizure calendar

    3. Structural and Functional Neuroimaging [Baseline and week 13]

      Brain MRI scans

    Secondary Outcome Measures

    1. Beck Depression Inventory-II (BDI-II) [Baseline, Weeks 1,2,3,4,5,6,7,8,9,10,11,12, 8 months post baseline, 12 months post baseline]

      The BDI-II assesses depression severity from "0" (no Depression-related symptom) to "3" (severe) on each question. The highest possible score is "51", relating to the worst outcome.

    2. Beck Anxiety Inventory (BAI) [Baseline, Weeks 6 and 10, 8 months post baseline, 12 months post baseline]

      The BDI-II assesses anxiety severity from "0" (no Anxiety-related symptom) to "3" (severe) on each question.

    3. Quality of Life in Epilepsy-31 (QOLIE-31) [Baseline, Weeks 6 and 10]

      his is a 31-item self-report scale used in the seizure population to evaluate Quality of Life. The lowest possible score is 0 and the highest possible score is 100, reflecting a better quality of life.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Inclusion criteria for PNES, ES and TBI (w/o PNES or ES) participants

    • Individuals with history of documented TBI (any severity).

    • Males and Females ages 18-60 years .

    • Women of child bearing potential, if currently using appropriate contraception.

    Inclusion criteria of PNES and ES participants.

    • Diagnosed by video/EEG with lone PNES or by EEG with lone ES.

    • Patients must have at least 1 PNES or 1 ES during the year prior to enrollment.

    Exclusion Criteria:
    • Exclusion Criteria of PNES, ES and TBI (w/o PNES or ES) participants

    • Current or past year self-injurious behavior.

    • Current suicidal intent (BDI suicide question 9 score of >1).

    • Current or past year psychosis.

    • Pending litigation or current application for long term disability.

    • Active substance or alcohol use disorder (dependence), per discretion of the investigators.

    • Serious illness requiring systemic treatment or hospitalization; the participant either completes therapy or is clinically stable on therapy, for at least 30 days prior to study entry.

    • Inability to fill out the self-report surveys.

    • Women who are or/are attempting to become pregnant during the study.

    • Ineligible or unwilling to complete MRI imaging.

    • Inability to document TBI.

    Exclusion Criteria for PNES and ES participants

    • Inability or unwillingness to participate in CBT and assigned homework.

    • Currently enrolled in cognitive therapy aimed at PNES (Current CBT or other psychotherapy may be administered).

    • Concurrent mixed ES/PNES or equivocal video/EEG findings in discerning between ES and PNES will not be enrolled.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Alabama at Birmingham Birmingham Alabama United States 35294
    2 Rhode Island Hospital Providence Rhode Island United States 02903
    3 Providence VA Medical Center Providence Rhode Island United States 02908

    Sponsors and Collaborators

    • Providence VA Medical Center
    • University of Alabama at Birmingham
    • Rhode Island Hospital
    • Birmingham, Alabama VA Medical Center
    • United States Department of Defense
    • Ocean State Research Institute, Inc.
    • Brown University

    Investigators

    • Principal Investigator: W. Curt LaFrance, Jr., MD, MPH, Providence VA Medical Center
    • Principal Investigator: Jerzy Szarflarski, MD, University of Alabama at Birmingham

    Study Documents (Full-Text)

    More Information

    Publications

    Responsible Party:
    Providence VA Medical Center
    ClinicalTrials.gov Identifier:
    NCT03441867
    Other Study ID Numbers:
    • Award Number W81XWH-17-1-0619
    First Posted:
    Feb 22, 2018
    Last Update Posted:
    Apr 5, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Providence VA Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 5, 2022